ASSET | DATE | % RETURN |
---|---|---|
ProQR Therapeutics (PRQR) | 9/1/2018 - 9/11/2018 | 180.52% |
Quantum BioPharma (QNTM) | 9/1/2018 - 9/11/2018 | 136.61% |
Netcapital (NCPL) | 9/1/2018 - 9/11/2018 | 100% |
Delcath Systems (DCTH) | 9/1/2018 - 9/11/2018 | 96.59% |
Iveda Solutions (IVDA) | 9/1/2018 - 9/11/2018 | 71.43% |
Lixte Biotechnology (LIXT) | 9/1/2018 - 9/11/2018 | 69.71% |
Processa Pharmaceuticals (PCSA) | 9/1/2018 - 9/11/2018 | 50% |
Scholar Rock (SRRK) | 9/1/2018 - 9/11/2018 | 48.6% |
CEL-SCI (CVM) | 9/1/2018 - 9/11/2018 | 47.33% |
OLB (OLB) | 9/1/2018 - 9/11/2018 | 44.17% |
Intellinetics (INLX) | 9/1/2018 - 9/11/2018 | 39.86% |
Castellum (CTM) | 9/1/2018 - 9/11/2018 | 39.24% |
Tilray (TLRY) | 9/1/2018 - 9/11/2018 | 37.53% |
Oxbridge Re (OXBR) | 9/1/2018 - 9/11/2018 | 37.14% |
Rimini Street (RMNI) | 9/1/2018 - 9/11/2018 | 35.79% |
Arrowhead Pharmaceuticals (ARWR) | 9/1/2018 - 9/11/2018 | 35.75% |
MetaVia (MTVA) | 9/1/2018 - 9/11/2018 | 32.87% |
Reliance Global (RELI) | 9/1/2018 - 9/11/2018 | 32.81% |
MCBC (MCFT) | 9/1/2018 - 9/11/2018 | 32.26% |
TSS, Inc Common Stock (TSSI) | 9/1/2018 - 9/11/2018 | 31.75% |
Sphere 3D (ANY) | 9/1/2018 - 9/11/2018 | 31.03% |
AudioEye (AEYE) | 9/1/2018 - 9/11/2018 | 30.71% |
Red Cat (RCAT) | 9/1/2018 - 9/11/2018 | 30% |
Turning Point Brands (TPB) | 9/1/2018 - 9/11/2018 | 29.22% |
Krystal Biotech (KRYS) | 9/1/2018 - 9/11/2018 | 27.43% |